BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 24761896)

  • 1. Knockdown of GCF2/LRRFIP1 by RNAi causes cell growth inhibition and increased apoptosis in human hepatoma HepG2 cells.
    Li JP; Cao NX; Jiang RT; He SJ; Huang TM; Wu B; Chen DF; Ma P; Chen L; Zhou SF; Xie XX; Luo GR
    Asian Pac J Cancer Prev; 2014; 15(6):2753-8. PubMed ID: 24761896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The E2F transcription factor 1 transactives stathmin 1 in hepatocellular carcinoma.
    Chen YL; Uen YH; Li CF; Horng KC; Chen LR; Wu WR; Tseng HY; Huang HY; Wu LC; Shiue YL
    Ann Surg Oncol; 2013 Nov; 20(12):4041-54. PubMed ID: 22911364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hint1 suppresses migration and invasion of hepatocellular carcinoma cells in vitro by modulating girdin activity.
    Wu XS; Bao TH; Ke Y; Sun DY; Shi ZT; Tang HR; Wang L
    Tumour Biol; 2016 Nov; 37(11):14711-14719. PubMed ID: 27623945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SND1 affects proliferation of hepatocellular carcinoma cell line SMMC-7721 by regulating IGFBP3 expression.
    Yin J; Ding J; Huang L; Tian X; Shi X; Zhi L; Song J; Zhang Y; Gao X; Yao Z; Jing X; Yang J
    Anat Rec (Hoboken); 2013 Oct; 296(10):1568-75. PubMed ID: 23878061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The influence of downregulation of ezrin expression by RNA interference on the growth and metastasis of hepatocellular carcinoma: experiment in vitro].
    Zhang Y; Hu MY; Chen BH; Wang ZJ; Zha XL; Liu KD
    Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(8):530-5. PubMed ID: 16681881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inhibition of SMYD3 gene expression by RNA interference induces apoptosis in human hepatocellular carcinoma cell line HepG2].
    Xu JY; Chen LB; Xu JY; Yang Z; Wei HY; Xu RH
    Ai Zheng; 2006 May; 25(5):526-32. PubMed ID: 16687068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IQGAP1 gene silencing induces apoptosis and decreases the invasive capacity of human hepatocellular carcinoma cells.
    Zoheir KM; Abd-Rabou AA; Harisa GI; Kumar A; Ahmad SF; Ansari MA; Abd-Allah AR
    Tumour Biol; 2016 Oct; 37(10):13927-13939. PubMed ID: 27488117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of MiR-93 expression reduces cell proliferation and clonogenicity of HepG2 cells.
    Xu D; He XX; Chang Y; Sun SZ; Xu CR; Lin JS
    Hepatogastroenterology; 2012; 59(120):2367-73. PubMed ID: 22773266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of lentiviral-mediated Foxp1 and Foxq1 RNAi on the hepatocarcinoma cell.
    Qin J; Xu Y; Li X; Wu Y; Zhou J; Wang G; Chen L
    Exp Mol Pathol; 2014 Feb; 96(1):1-8. PubMed ID: 24211718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen activates PEG10 to promote carcinogenesis in hepatic cancer cells.
    Jie X; Lang C; Jian Q; Chaoqun L; Dehua Y; Yi S; Yanping J; Luokun X; Qiuping Z; Hui W; Feili G; Boquan J; Youxin J; Jinquan T
    Oncogene; 2007 Aug; 26(39):5741-51. PubMed ID: 17369855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aflatoxin B1 promotes cell growth and invasion in hepatocellular carcinoma HepG2 cells through H19 and E2F1.
    Lv J; Yu YQ; Li SQ; Luo L; Wang Q
    Asian Pac J Cancer Prev; 2014; 15(6):2565-70. PubMed ID: 24761865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance and therapeutic potential of eukaryotic translation initiation factor 5A (eIF5A) in hepatocellular carcinoma.
    Lee NP; Tsang FH; Shek FH; Mao M; Dai H; Zhang C; Dong S; Guan XY; Poon RT; Luk JM
    Int J Cancer; 2010 Aug; 127(4):968-76. PubMed ID: 19998337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of HDAC5 inhibits growth of human hepatocellular carcinoma by induction of apoptosis and cell cycle arrest.
    Fan J; Lou B; Chen W; Zhang J; Lin S; Lv FF; Chen Y
    Tumour Biol; 2014 Nov; 35(11):11523-32. PubMed ID: 25129440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatoma-derived growth factor/nucleolin axis as a novel oncogenic pathway in liver carcinogenesis.
    Chen SC; Hu TH; Huang CC; Kung ML; Chu TH; Yi LN; Huang ST; Chan HH; Chuang JH; Liu LF; Wu HC; Wu DC; Chang MC; Tai MH
    Oncotarget; 2015 Jun; 6(18):16253-70. PubMed ID: 25938538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RFX-1-dependent activation of SHP-1 inhibits STAT3 signaling in hepatocellular carcinoma cells.
    Su JC; Chiang HC; Tseng PH; Tai WT; Hsu CY; Li YS; Huang JW; Ko CH; Lin MW; Chu PY; Liu CY; Chen KF; Shiau CW
    Carcinogenesis; 2014 Dec; 35(12):2807-14. PubMed ID: 25322871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HDAC inhibition activates the apoptosome via Apaf1 upregulation in hepatocellular carcinoma.
    Buurman R; Sandbothe M; Schlegelberger B; Skawran B
    Eur J Med Res; 2016 Jun; 21(1):26. PubMed ID: 27342975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-183 inhibits TGF-beta1-induced apoptosis by downregulation of PDCD4 expression in human hepatocellular carcinoma cells.
    Li J; Fu H; Xu C; Tie Y; Xing R; Zhu J; Qin Y; Sun Z; Zheng X
    BMC Cancer; 2010 Jul; 10():354. PubMed ID: 20602797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of FOXF2 Expression Predicts Poor Prognosis in Hepatocellular Carcinoma Patients.
    Shi Z; Liu J; Yu X; Huang J; Shen S; Zhang Y; Han R; Ge N; Yang Y
    Ann Surg Oncol; 2016 Jan; 23(1):211-7. PubMed ID: 25824262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KITENIN is associated with activation of AP-1 target genes via MAPK cascades signaling in human hepatocellular carcinoma progression.
    Cho SB; Park YL; Park SJ; Park SY; Lee WS; Park CH; Choi SK; Heo YH; Koh YS; Cho CK; Chung IJ; Kim KK; Kim S; Joo YE
    Oncol Res; 2011; 19(3-4):115-23. PubMed ID: 21473287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of WWP1 promotes tumorigenesis and predicts unfavorable prognosis in patients with hepatocellular carcinoma.
    Zhang XF; Chao J; Pan QZ; Pan K; Weng DS; Wang QJ; Zhao JJ; He J; Liu Q; Jiang SS; Chen CL; Zhang HX; Xia JC
    Oncotarget; 2015 Dec; 6(38):40920-33. PubMed ID: 26506518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.